Clinical Trials in Arizona

Showing 6341-6360 of 12,706 trials

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

NCT01147666

The primary objective of this study is to evaluate the efficacy and safety of roxadustat in participants with end-stage renal disease (ESRD) on maintenance hemodialysis (HD) therapy, previously treated with intravenous (IV) epoetin alfa.

End Stage Renal DiseaseAnemia

Kyntra Bio161 participantsStarted May 2010

Tempe, Arizona, United States • Pine Bluff, Arkansas, United States • Azusa, California, United States +22 more locations

COMPLETEDPhase 142 miles

RJV001 Study in Adults Receiving Abdominoplasty

NCT04821648

In this study, we are testing a new drug against submental fat (SMF), which is characterized with the accumulation of fat under the chin that often appears as a "double chin". The 2018 American Society for Dermatologic Surgery Consumer Survey on Cosmetic Dermatologic Procedures indicated that 73% of respondents were bothered by "excess fat under the chin/neck". This condition of loose or sagging skin under the chin may affect facial symmetry and attractiveness, which can lead to social embarrassment and a negative self-image in many patients. There is an insufficiency in effective drugs against SMF and double chin. Although an injectable small molecule can be used for improvement of double chin, but its side effects are evident and its cost is high. As such, there remains a real need to develop a cost-effective method to improve appearance of SMF and double chin.

Submental Fat (SMF)Double Chin

Rejuven Dermaceutical Co., Ltd.18 participantsStarted Apr 2021

Phoenix, Arizona, United States

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

RJV001 Study in Adults Receiving Abdominoplasty

Find Trials by Condition in Arizona

Phase 4 IOP Signals Associated With ILUVIEN®

The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Clinical Study of a Diagnostic Device for NG, TV and CT in Women

The DEPOT Study (Dry Eye Prescription Options for Therapy)

A Study of CNSA-001 in Women With Diabetic Gastroparesis

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Comparative Bioavailability of Risperidone.

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

ERAS® Guidelines Validation of CRS With or Without HIPEC